Pharmacyte Biotech Inc (PMCB) stock is down -27.08% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives PMCB stock a score of 16 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 21. PMCB's rank also includes a short-term technical score of 26. PMCB has an Overall Score of 16. Find out what this means to you and get the rest of the rankings on PMCB!